Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial
Nicholas A. Vitanza, Rebecca Ronsley, Michelle Choe et al. · Nature Medicine · 2025
Full textCC BY
Oncology
Filters3 filters applied
Status
- Expression of concern
- Corrected
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai et al. · Signal Transduction and Targeted Therapy · 2025 · Review
Full textCC BY
Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status
Shuai Xu, Sara Murtagh, Yunan Han et al. · JAMA Network Open · 2024
Full textCC BY
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
Tong Chen, Mingzhao Wang, Yanchao Chen et al. · Cancer Cell International · 2024 · Review
Full textCC BY
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
Lucie Thorel, Marion Perréard, Romane Florent et al. · Experimental & Molecular Medicine · 2024 · Review
Full textCC BY
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma
Frederick L. Locke, Simone Filosto, Justin Chou et al. · Nature Medicine · 2024
Full textCC BY
Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis
Taha Koray Sahin, Alessandro Rizzo, Sercan Aksoy et al. · Cancers · 2024 · Review
Full textCC BY
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial
Tanya B. Dorff, M. Suzette Blanchard, Lauren N. Adkins et al. · Nature Medicine · 2024
Full textCC BY
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis
Taha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo et al. · Cancers · 2024 · Review
Full textCC BY
Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen et al. · Molecular Cancer · 2024 · Review
Full textCC BY
CAR T therapies in multiple myeloma: unleashing the future
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini et al. · Cancer Gene Therapy · 2024 · Review
Full textCC BY
Corrected Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial
Nadia Harbeck, Eva Ciruelos, Guy Jerusalem et al. · Nature Medicine · 2024
Full textCC BY
An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity
Nina E. Weisser, Mario Sanches, Eric Escobar-Cabrera et al. · Nature Communications · 2023
Full textCC BY
Advances in the role of STAT3 in macrophage polarization
Tingting Xia, Meng Zhang, Wei Lei et al. · Frontiers in Immunology · 2023 · Review
Full textCC BY
Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020)
Nayili Mahemuti, Xiyue Jing, Naijian Zhang et al. · Nutrients · 2023
Full textCC BY
Role of p53 in breast cancer progression: An insight into p53 targeted therapy
Charlie Marvalim, Arpita Datta, Soo Chin Lee · Theranostics · 2023 · Review
Full textCC BY
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
Peng Zhang, Aida Rashidi, Junfei Zhao et al. · Nature Communications · 2023
Full textCC BY
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Grace Guzman, Megan R. Reed, Kevin Bielamowicz et al. · Current Oncology Reports · 2023 · Review
Full textCC BY
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial
Dion Morton, Matthew Seymour, Laura Magill et al. · Journal of Clinical Oncology · 2023 · Randomised trial
Full textCC BY
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh et al. · Frontiers in Immunology · 2023 · Review
Full textCC BY